Translation of "Subarachnoid hemorrhage" in German

Anyway, actual cause of death is subarachnoid hemorrhage.

The impact caused a subarachnoid hemorrhage resulting in global aphasia.

His laboratory investigates mechanisms and pathophysiology of cerebral vasospasm after subarachnoid hemorrhage.

It shows a small subarachnoid hemorrhage.

Charlie Whaling, nine years old, presented with a subarachnoid hemorrhage after automobile collision.

You have a subarachnoid hemorrhage.

CT ruled out subdural hematoma, stroke, or subarachnoid hemorrhage.

The prognosis after a subarachnoid hemorrhage depends on the size and severity of the bleed.

In particular, they show endothelin receptor-antagonistic properties and can therefore be employed for the treatment of illnesses such as hypertension, cardiac insufficiency, coronary heart disease, renal, cerebral and myocardial ischaemia, renal insufficiency, cerebral infarct, subarachnoid hemorrhage, arteriosclerosis, pulmonary high blood pressure, inflammations, asthma, prostate hyperplasia, endotoxic shock and in the case of complications after the administration of substances such as cyclosporin, and also other illnesses associated with endothelin activities.

Further examples of disorders which can be treated are renal insufficiency and renal failure, dialysis, subarachnoid hemorrhage, Raynaud?s syndrome, portal hypertension and pulmonary hypertension, and the treatment of gastric and duodenal ulcers and of leg ulcer in which vasoconstriction is involved.

The diagnosis was made almost immediately, thanks to an experienced doctor. He said that subarachnoid hemorrhage is a serious matter, but it can be cured, especially the early stages, like mine.

Diagnosing a thunderclap headache as migraine because a triptan relieves it (a triptan can also relieve a headache due to subarachnoid hemorrhage)

Nimotop is used to decrease problems due to a certain type of bleeding in the brain (subarachnoid hemorrhage).

The age-adjusted mortality rates due to ischemic and hemorrhagic stroke have markedly declined in recent decades in Western industrialized countries (8), as have the mortality rates due to subarachnoid hemorrhage (9, 10).

A good response to dihydroergotamine or a triptan should not be interpreted as diagnostic for migraine because these drugs may relieve headache due to subarachnoid hemorrhage and other structural abnormalities.

Other possible causes include complications of prematurity such as intraventricular haemorrhage, diseases such as meningitis, tumors, head trauma or subarachnoid hemorrhage that blocks the exit of the ventricles to the cisterns and the flow of fluid in them. Â

What is a subarachnoid hemorrhage?

The drug is prescribed to patients who need effective treatment, recovery, and prevention of ischemic neurological disorders resulting from spasms of cerebral vessels in the background of subarachnoid hemorrhage after aneurysm rupture.

In this case, the use of the drug intravenously begins four days after the patient has been found to have subarachnoid hemorrhage.

In hemorrhagic strokes, bleeding may occur either within the brain (intracerebral hemorrhage) or may occur between the inner and middle layer of tissue covering the brain (subarachnoid hemorrhage).

Three days later, for the prevention of thromboembolism in the presence of pronounced signs of subarachnoid hemorrhage and atherosclerosis, the patient is assigned proteolytic enzymes (Kontrikal, Gordoks) in combination with Heparin.

Today, it is one of the best medicines used in the recovery of patients after subarachnoid hemorrhage, which saves lives and helps to trigger brain functions.

A bullet had ruptured his orbital plate causing subarachnoid hemorrhaging.

An effective amount of transglutaminases for inhibiting the damage in tissue at risk during reperfusion, in inflammatory processes, subarachnoid hemorrhages, autoimmune diseases, degenerative disorders, arteriosclerosis, neoplastic diseases (such as leukemias, histiocytosis X and others), hyperergic/allergic disorders, post-burn disorder, transplant incompatibility, premature detachment of the placenta and pre-eclampsia, shock syndrome, depends on a number of factors, for example the age and the weight of the patient and the clinical condition.

The compounds of the present invention provide a novel therapeutic potential for the treatment of hypertension, pulmonary hypertension, myocardial infarct, angina pectoris, acute kidney failure, renal insufficiency, cerebral vasospasms, cerebral ischemia, subarachnoid hemorrhages, migraine, asthma, atherosclerosis, endotoxic shock, endotoxin-induced organ failure, intravascular coagulation, restenosis after angioplasty, benign prostate hyperplasia, or hypertension or kidney failure caused by ischemia or intoxication, and cancers, especially prostate and skin cancer.

The compounds of the present invention provide a novel therapeutic potential for the treatment of hypertension, pulmonary hypertension, myocardial infarct, angina pectoris, acute kidney failure, renal insufficiency, cerebral vasospasms, cerebral ischemia, subarachnoid hemorrhages, migraine, asthma, atherosclerosis, endotoxic shock, endotoxin-induced organ failure, intravascular coagulation, restenosis after angioplasty, benign prostate hyperplasia, or hypertension or kidney failure caused by ischemia or intoxication.

With this method, subdural and subarachnoidal hemorrhages as well as epidural hemorrhages of the entire skull can be presented along a single layer.

The present amides I can accordingly be used for the treatment of neurodegenerative diseases which occur after ischemia, trauma, subarachnoid hemorrhages and stroke, and of neurodegenerative diseases such as multiple infarct dementia, Alzheimer?s disease, Huntington?s disease and of epilepsies and furthermore for the treatment of damage to the heart after cardiac ischemia, reperfusion damage after vascular occlusion, damage to the kidneys after renal ischemia, skeletal muscle damage, muscular dystrophy, damage which occurs due to proliferation of the smooth muscle cells, coronary vasospasms, cerebral vasospasms, cataracts of the eyes, restenosis of the blood vessels after angioplasty.

The compounds of the present invention offer a novel potential therapy for the treatment of hypertension, pulmonary hypertension, myocardial infarct, angina pectoris, acute kidney failure, renal insufficiency, cerebral vasospasms, cerebral ischemia, subarachnoid hemorrhages, migraine, asthma, atherosclerosis, endotoxic shock, endotoxin-induced organ failure, intravascular coagulation, restenosis after angioplasty, benign prostate hyperplasia, kidney failure caused by ischemia and by intoxication, and hypertension, and of cancers, in particular prostate cancer and skin cancer.

The present 2-phenylbenzimidazoles and 2-phenylindoles of the general formula I can accordingly be used for the treatment and prophylaxis of neurodegenerative diseases which occur after ischemia, trauma (craniocerebral trauma), mass hemorrhages, subarachnoid hemorrhages and stroke, and of neurodegenerative diseases such as multiple infarct dementia, Alzheimer?s disease, Huntington?s disease and of epilepsies, in particular of generalized epileptic attacks, such as, for example, petit mal and tonic-clonic attacks and partial epileptic attacks, such as temporal lobe and complex partial attacks, and furthermore for the treatment and prophylaxis of damage to the heart after cardiac ischemia and damage to the kidneys after renal ischemia, for example of acute renal insufficiency, of acute kidney failure or of damage which occurs during and after a kidney transplant.

The compounds according to the invention are suitable for the prophylaxis and/or treatment of cardiovascular disorders such as, for example, hypertension and cardiac insufficiency, stable and unstable angina pectoris, disorders of peripheral and cardiac vessles, of arrhythmias, of thrombolic disorders and ischemias, such as myocardial infarction, stroke, transitory and ischemic attacks, obstruction of peripheral circulation, subarachnoidal hemorrhages, prevention of restenoses, such as, for example, after thrombolysis therapies, percutaneous translumino angioplasties (PTA) percutaneous transluminal coronary angioplasties (PTCA), bypass, and for the prophylaxis and/or treatment of arteriosclerosis, asthmatic disorders, COPD and diseases of the urogenital system, such as, for example, prostate hypertrophy, erectile dysfunction, female sexual dysfunction, osteoporosis, gastroparesis and incontinence.

The present 2-phenylbenzimidazoles of the general formula I can accordingly be used for the treatment and prophylaxis of neurodegenerative diseases occurring after ischemia, trauma (craniocerebral trauma), massive bleeding, subarachnoid hemorrhages and stroke, and of neurodegenerative diseases such as multi-infarct dementia, Alzheimer's disease, Huntington's disease and of epilepsies, in particular of generalized epileptic seizures, such as, for example, petit mal and tonoclonic seizures and partial epileptic seizures such as temporal lope, and complex partial seizures, and further for the treatment and prophylaxis of damage to the heart after cardiac ischemia and damage to the kidneys after renal ischemia, for example of acute renal insufficiency, of acute kidney failure or of damage occurring during and after a kidney transplant.

Accordingly, the present amides I can be used for treating neurodegenerative diseases which occur following ischemia, trauma, subarachnoidal hemorrhages and stroke, and for treating neurodegenerative diseases such as multiple infarction dementia, Alzheimer?s disease and Huntington?s disease, and for treating epilepsies, and, furthermore, for treating damage to the heart following cardiac ischemias, damage to the kidneys following renal ischemias, skeletal muscle damage, muscular dystrophies, damage which arises due to proliferation of the smooth muscle cells, coronary vasospasms, cerebral vasospasms, cataracts of the eyes and restenosis of the blood vessels following angioplasty.